Jan Koedam

Jan Koedam is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as the VP Head of Clinical International at Cabaletta Bio since July 2024. Prior experience includes roles at AvenCell as VP Head of Clinical Development & Medical Affairs from April 2020 until July 2024, and leading Clinical Development & Medical Affairs at GEMoaB GmbH prior to its rebranding to AvenCell Europe GmbH in December 2021. Jan Koedam's extensive career at Celgene spanned over 13 years, including positions such as CAR-T lead for Central Northern Europe and Director Early Development. Additionally, Jan Koedam held significant roles at Novartis, Aventis Pharmaceuticals, and Pharmacia, beginning as a Clinical Research Associate in 1996 and progressing through various leadership positions. Jan Koedam holds a Master of Science degree in Medical Biology and completed education at Koningin Wilhelmina College between 1982 and 1987.